Medicus Pharma Ltd (MDCX)

11:35 AM

Medicus Pharma submits optimized Phase 2 study design for Teverelix - Proactive financial news

11:35 AM

10:30 AM

Market movers: Virgin Galactic, Soleno Therapeutics, Medicus Pharma... - Proactive financial news

10:30 AM

09:52 AM

Medicus Pharma Streamlines Phase 2 Teverelix Trial for $2 Billion AUR Market - TipRanks

09:52 AM

08:38 AM

Medicus Pharma submits optimized Phase 2 Teverelix trial protocol to FDA - finance.yahoo.com

08:38 AM

07:30 AM

Medicus targets recurrent urinary retention with 126-patient study - Stock Titan

07:30 AM

07:16 AM

EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate - Benzinga

07:16 AM

Apr 05, 2026

Medicus Pharma submits optimized Phase 2 protocol for Teverelix - grafa.com

Apr 05, 2026

Apr 04, 2026

Medicus Pharma SkinJect Phase 2 study data endorsed by independent expertICYMI - Proactive financial news

Apr 04, 2026

Apr 04, 2026

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - gosanangelo.com

Apr 04, 2026

Apr 03, 2026

Medicus Pharma stock swings after skin cancer treatment results - MSN

Apr 03, 2026

Apr 03, 2026

Medicus Pharma on Bloomberg World - Bluffton Today

Apr 03, 2026

Apr 02, 2026

Medicus Pharma Ltd. (MDCX) stock price, news, quote and history - Yahoo Finance Singapore

Apr 02, 2026

Apr 02, 2026

Medicus Pharma clarifies Phase 2 skin cancer study results By Investing.com - Investing.com South Africa

Apr 02, 2026

Apr 02, 2026

MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 02, 2026

MDCX Forecast, Price Target & Analyst Ratings | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

Apr 02, 2026

Apr 01, 2026

Medicus Pharma (MDCX) COO granted 50,000 options at $0.50 exercise price - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Medicus Pharma (NASDAQ: MDCX) awarded 25,000 stock options at $0.50 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Medicus Pharma (NASDAQ: MDCX) receives 25,000 stock options at $0.50 strike - Stock Titan

Apr 01, 2026

Apr 01, 2026

CMO at Medicus Pharma (MDCX) receives 125,000 stock options grant - Stock Titan

Apr 01, 2026

Apr 01, 2026

[Form 4] Medicus Pharma Ltd. Insider Trading Activity - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (MDCX) director granted stock options for 25,000 Common Shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director Barry Fishman granted 25,000 Medicus Pharma (MDCX) stock options - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (MDCX) grants director 25K stock options at $0.50 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (MDCX) Chief Scientific Officer receives 25,000 stock options grant - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (MDCX) grants CFO 100,000 stock options - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (NASDAQ: MDCX) CEO awarded 325,000 options at $0.50 strike - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma (NASDAQ: MDCX) director receives grant of 25,000 options at $0.50 strike - Stock Titan

Apr 01, 2026

Apr 01, 2026

Medicus Pharma eyes registrational study for SkinJect after positive Phase 2 data - Yahoo! Finance Canada

Apr 01, 2026

Apr 01, 2026

Medicus Pharma Ltd clarifies positive Skinject phase 2 dataset - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Medicus Pharma Ltd Clarifies Positive Skinject Phase 2 Dataset - TradingView

Apr 01, 2026

Apr 01, 2026

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset - The Manila Times

Apr 01, 2026

Apr 01, 2026

Medicus Pharma clarifies Phase 2 skin cancer study results - Investing.com

Apr 01, 2026

Apr 01, 2026

Skin cancer study points to stronger results at higher SkinJect dose - Stock Titan

Apr 01, 2026

Mar 31, 2026

MDCXW Financials: Income Statement, Balance Sheet & Cash Flow | Medicus Pharma Ltd - Stock Titan

Mar 31, 2026

Mar 31, 2026

MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

Mar 31, 2026

Mar 30, 2026

Ideas Watch: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackQuarterly Portfolio Summary & Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Small cap wrap: Namibia Critical Metals, Medicus Pharma, Greatland Resources... - Proactive financial news

Mar 30, 2026

Mar 30, 2026

Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate - TipRanks

Mar 30, 2026

Mar 30, 2026

Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2 - TipRanks

Mar 30, 2026

Mar 30, 2026

D. Boral Capital cuts Medicus Pharma stock price target on dilution concerns - ca.investing.com

Mar 30, 2026

Mar 30, 2026

Medicus Pharma highlights independent support for Phase 2 SkinJect results - Yahoo Finance

Mar 30, 2026

Mar 30, 2026

Medicus Pharma Ltd Reports KOL Validation of Skinject Phase 2 Data of 80% Overall Response Rate - MarketScreener

Mar 30, 2026

Mar 30, 2026

Medicus Pharma reports Kol validation of Skinject phase 2 data of 80% overall response rate - MarketScreener

Mar 30, 2026

Mar 30, 2026

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate - Caledonian Record

Mar 30, 2026

Mar 30, 2026

[EFFECT] Medicus Pharma Ltd. SEC Filing - Stock Titan

Mar 30, 2026

Mar 27, 2026

Bull Bear: Is Medicus Pharma Ltd Equity Warrant stock forming a cup and handleMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Free cash flow per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Mar 27, 2026

Mar 27, 2026

Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026 - openPR.com

Mar 27, 2026

Mar 27, 2026

Medicus Pharma reports 80% response rate in skin cancer study By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 27, 2026

Medicus Pharma to host business update call featuring clinical investigator - MSN

Mar 27, 2026